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SI Materials and Methods
Materials. Chemicals used in the study were purchased from Sigma, restriction enzymes from Amersham Pharmacia, DNA purification kits from Qiagen, mammalian cell culture reagents and the HEK 293 cell line from Invitrogen, and NIH 3T3 cells from ATCC. Sequences of primers used in the study are available upon request.
Databases and programs. Toxoplasma gondii, C. elegans, human and mouse genome sequences and nonredundant protein sequences (ftp://ftp.ncbi.nih.gov/genbank) were obtained from NCBI. SECISearch was used for identification of candidate SECIS elements (1). BLAST and FASTA programs were used for similarity searches (2).
Identification of homologs of known selenoprotein genes.
A full set of known eukaryotic selenoproteins was used as query sequences and included all human selenoproteins (1), all Plasmodium falciparum selenoproteins (3), Chlamydomonas MsrA (4), Gallus gallus SelU (5), protein disulfide isomerase from Emiliania huxleyi (6) and Danio rerio Fep15 (7). A stand-alone version of TBLASTN and FASTA package were used for detection of nucleotide sequences corresponding to known selenoprotein families.
A search for canonical Toxoplasma SECIS elements. A stand-alone version of SECISearch with the default pattern was used. The search procedure included the following steps:
1. Analysis of primary nucleotide sequence and secondary structures. We used PatScan to search the target database for the candidates satisfying the NUGA__AA__GA pattern. This pattern represents almost all eukaryotic SECIS elements (8). The additional requirements were as follows: (i) distance between the quartet (NUGA) and the unpaired AA in the apical loop 10-13 nucleotides, (ii) length of the apical loop without the unpaired AA sequence 6-23 nucleotides, (iii) no more than one insertion, one deletion, and two mismatches in the stem preceding the unpaired AA, and (iv) presence of an additional stem upstream of the quartet. For each SECIS candidate found in the previous step, secondary structure was predicted and examined for consistency with the eukaryotic SECIS consensus model. Additional filters then excluded SECIS elements with more than two consecutive unpaired nucleotides and Y-shaped SECIS elements.
2. Estimation of the free energy. RNAfold from Vienna RNA package was used to calculate the free energies for whole structures and separately for their upper stem-loops. The threshold value was -12.6 kcal/mol for the whole structure and -3.7 kcal/mol for the upper stem-loop.
3. Protein identification. Analysis of location of SECIS elements and identification of ORFs were carried out. Candidate structures located on the complementary strand were filtered out.
4. ORF analysis. This final step consisted of sequence analyses of predicted ORFs and identification of candidate Sec-encoding UGA codons.
A search for Toxoplasma noncanonical SECIS elements. The search for noncanonical SECIS elements was carried out as described above for canonical SECIS elements, except that NTGA was replaced by NGGA in the primary sequence. Although no non-canonical SECIS elements other than the GGGA-type structures were discovered by homology searches involving known selenoproteins, the search settings were relaxed to allow any nucleotide preceding GGA (or UGA) for better sensitivity.
Analysis of mammalian and nematode genomes, and EST sequences. Analysis of human and mouse genomes was carried out as described in ref. 1, with search patterns modified to meet the modified SECIS consensus model (e.g., GGGA-and AUGA-type SECIS elements). Likewise, similar modifications were made in the nematode search procedure (10). In addition to completely sequenced genomes, the NCBI EST database was searched for the presence of NGGA-type SECIS elements.
Cloning strategies. GFP-fusion constructs developed and used in the study are shown in the scheme in Fig. 3A . Selenoprotein H (SelH) cDNA containing the in-frame TGA codon but lacking the entire 3'-UTR was amplified and cloned into pEFGP-C3 (Clontech), and all subsequent constructs containing Toxoplasma SECIS elements were developed using this GFP-SelHD3'UTR fusion construct (construct 2 in Fig. 3A) . Toxoplasma SelT and SelS SECIS elements (130-bp region, constructs 3 and 5, respectively) or the sequences beginning with the corresponding stop codons and containing SECIS elements (»300-bp region, constructs 4 and 6) were amplified and cloned immediately downstream of the SelH stop codon. The rationale was as follows: the SelH SECIS is located very close to the stop codon (construct 1). Therefore, the constructs having the 130-bp sequences of Toxoplasma SECIS elements were regarded as corresponding to substitution of the mammalian SECIS element with the Toxoplasma structures, whereas the constructs containing the 300-bp sequences of Toxoplasma SelT 3'-UTR or 350-bp sequence of Toxoplasma SelS 3'UTRs were substitutions that introduced the corresponding 3'-UTRs.
We further mutated the GG bases in the SECIS quartet in both Toxoplasma SelT and SelS to AT (i.e., Toxoplasma GG to AT mutants). Likewise, the AT bases in GFP-mSelHwt, GFP-mSelSwt, and GFPmSelMwt (Fig. 4A) fusions were mutated to the GG (i.e., mouse AT to GG mutants) using QuickChange mutagenesis kit (Stratagene).
The vector for expression of selenoproteins in mammalian cells was developed on the basis of pBudCE4.1 (Invitrogen). First, the C-terminal domain of rat SBP2 was cloned into the first cloning site for expression under the EF 1apromoter. Subsequently, the Toxoplasma SelT AT>GG SECIS was cloned into the second multiple cloning site. Finally, mouse GPx1 sequence containing an in-frame TGA codon, but lacking a 3'-UTR, was amplified and cloned into the vector. As a control, we used the construct wherein mGPx1-Toxoplasma SelT SECIS AT>GG mutant was cloned into pBudCE4.1 that did not have the rat SBP2 sequence.
Cell culture, transfection, and metabolic labeling. Mouse NIH 3T3 and human HEK 293 cells were cultured in DMEM supplemented with 10% FBS, 100 units/ml penicillin, and 100 units/ml streptomycin. Cells were seeded in six-well plates and transfected as follows: NIH 3T3 cells using Lipofectamin and Plus reagent (Invitrogen) according to the manufacturer's protocol, and HEK 293 using the calciumphosphate method (9) in OPTI-MEM (Invitrogen), or cotransfected in a ratio of 2:1 with the rat SBP2 expression construct (20) that was the generous gift of Drs. Paul Copeland and Donna Driscoll, Cleveland Clinic Foundation. In 12-24 h after transfection, the medium was replaced with DMEM supplemented with Se (specific activity 1,000 Ci/mmol), and the cells were incubated for an additional 12-24 h.
SDS/PAGE and Western blot analysis.
After transfection, cells were washed with PBS, harvested, lysed in 200 ml of lysis buffer (Sigma), electrophoresed using NuPAGE system (Invitrogen), and transferred onto PVDF membranes. The membranes were exposed to a PhosphorImager screen and metabolically labeled proteins were visualized using a PhosphorImager system (GE Healthcare). The membranes were then probed with anti-GFP rabbit antiserum (Invitrogen) as primary and anti-rabbit HRP-conjugated antibodies as secondary antibodies. The Western blot signals were then detected with an ECL system (GE Healthcare).
Enrichment of recombinant His-tagged GPx1 protein on metal-affinity resin.
Forty-eight hours after transfection of mammalian cells with various His tag-GPx1 expression constructs, the cells were harvested, lysed in PBS containing protease inhibitors (complete protease mixture, Roche) by brief sonication and centrifuged for 5 min. Supernatants were collected, normalized with respect to protein concentration using Bradford method (Bio-Rad), and mixed with TALON affinity resin (Clontech). Total protein (0.75 mg; 1 mg/ml, 750 ml) per 40-50 ml of the resin was used. The samples were incubated under delicate rotation for 1 h at 4°C. After incubation, the resins were washed extensively, and the bound proteins were eluted by heating in an SDS/PAGE loading buffer and analyzed by gel electrophoresis and immunoblotting. After analysis of Se-labeled proteins as described above, the membranes were probed in Western blots with anti-GPx1 antibodies (GeneTex) according to the manufacturer's protocol. 
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H.sapiens M.musculus D.rerio C.reinhardtii W1 C.reinhardtii W2 T.gondii N.caninum 1 MA---LAVRVVYCGAUGYKSKYLQLKKKLEDEFP----GRLDICGEGTPQATGFFEVMVA 1 MA---LAVRVVYCGAUGYKPKYLQLKEKLEHEFP----GCLDICGEGTPQVTGFFEVTVA 1 MT---VKVHVVYCGGUGYRPKFIKLKTLLEDEFP----NELEITGEGTPSTTGWLEVEVN 1 MAP--VQVHVLYCGGUGYGSRYRSLENAIRMKFPN---ADIKFSFEATPQATGFFEVEVN 1 MAKTSIAAQVVMCGGUGYRGRYRSLVEAYRRRFP----LWVPTSPTTQRCSLEAFEISVN 1 MEQT-VEITIQFCGGUGYRPYFDRAEALIRSWLSDAELRRVSIEGHEDPGTTGNFEIRIN 1 MART-VEITIQFCGGUGYRPYFDRAEALIRSWFTDVYFRHVSIEGHEDPGTTGNFEIRID H.sapiens 54 GKLIHSKK-KGDGYVDTESKFLKLV-AAIKAALAQG- M.musculus 54 GKLVHSKK-RGDGYVDTESKFRKLV-TAIKAALAQCQ D.rerio 54 GKLVHSKK-NGDGFVDSDSKMQKIV-TAIEQAMGK-- C.reinhardtii W1 56 GELVHSKK-NGGGHVDNQEKVERIF-AKIGEALAK-- C.reinhardtii W2 57 GGLVHSKE-KGMQFPYAPESWSGCT------------ T.gondii 60 GKLVHSKKTKKQGFLHANKEQQEVVRQKLKEALGN-- N.caninum 60 GVLVHSKKTRRQGFLHANKEQQEVVRQKIREALDN-
